Match Group Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Match Group Inc trades at $41.54 (market cap $9.53B), while Roivant Sciences Ltd. Common Shares trades at $34.67 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.6× Match Group Inc's market cap, and Match Group Inc pays a 1.93% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Match Group Inc for 115 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| MTCH | ROIV | |
|---|---|---|
Market Cap | $9.53B | $24.72B |
Volume | 3,228,794 | 6,279,442 |
Sector | Media | Health |
52-Week High | $44.40 | $41.81 |
52-Week Low | $28.90 | $16.04 |
Typical Hold Time | 115 Days | 0 Days |
Enterprise Value | $12.49B | $20.99B |
Dividend Yield | 1.93% | — |
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $40.86, up 0.59% on the day, with a bullish technical signal and strong analyst consensus. The stock shows robust fundamentals with a P/E of 14.71, net income margin of 20.17%, and consistent cash flow generation. Recent earnings beat expectations in Q2 2026, and positive news highlights product innovation and growth in Hinge.
The outlook is positive, supported by margin expansion and strategic initiatives, but risks include high debt levels and competitive pressures. Wall Street sentiment is bullish with a $42.29 price target, offering modest upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →